无骨髓增殖性肿瘤的中国深静脉血栓形成患者中JAK2V617F突变缺失 - Suppr | 超能文献

Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.

作者信息

Dong Bingfei, Zhang Yang, Fu Xueqi, Wang Guangyi

出版信息

Thromb Res. 2012 May;129(5):664-5. doi: 10.1016/j.thromres.2011.12.018. Epub 2011 Dec 22.

DOI:10.1016/j.thromres.2011.12.018

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.无骨髓增殖性肿瘤的中国深静脉血栓形成患者中JAK2V617F突变缺失

Thromb Res. 2012 May;129(5):664-5. doi: 10.1016/j.thromres.2011.12.018. Epub 2011 Dec 22.

2

Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.与内脏静脉血栓形成相关的JAK2 V617F突变的患病率：一项10年回顾性研究。

Thromb Haemost. 2009 Apr;101(4):787-9.

3

The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.在无明显慢性骨髓增殖性疾病的脑静脉血栓形成患者中，V617F JAK 2突变并不常见。

Thromb Haemost. 2008 Jun;99(6):1119-20. doi: 10.1160/TH08-02-0081.

4

The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal.脑静脉血栓形成患者中的JAK2 V617F突变：一篇反驳文章

Thromb Haemost. 2008 Jun;99(6):1121. doi: 10.1160/TH08-04-0205.

5

Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.下腔静脉血栓形成及其与 JAK2V617F 突变和慢性骨髓增殖性疾病的关系。

Thromb Res. 2012 Jun;129(6):720-4. doi: 10.1016/j.thromres.2011.09.011. Epub 2011 Oct 7.

6

JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases.与脑静脉血栓形成相关的JAK2 V617F突变：五例报告

Cerebrovasc Dis. 2010 Jan;29(2):206-9. doi: 10.1159/000267281. Epub 2009 Dec 18.

7

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.内脏静脉血栓形成且无明显骨髓增殖性肿瘤患者中JAK2外显子12突变缺失。

Am J Hematol. 2009 Feb;84(2):126-7. doi: 10.1002/ajh.21335.

8

JAK2V617F mutation in patients with splanchnic vein thrombosis.JAK2V617F 突变与肠系膜静脉血栓形成。

Dig Dis Sci. 2010 Jun;55(6):1770-7. doi: 10.1007/s10620-009-0933-y. Epub 2009 Aug 19.

9

JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes.JAK2V617F突变普遍存在于伴有骨髓增殖性综合征的内脏静脉血栓形成中。

Aliment Pharmacol Ther. 2011 Jun;33(12):1382-3. doi: 10.1111/j.1365-2036.2011.04670.x.

10

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.无明显骨髓增殖性疾病情况下非内脏静脉血栓形成中JAK2V617F的患病率和等位基因负荷。

Leukemia. 2007 Aug;21(8):1828-9. doi: 10.1038/sj.leu.2404710. Epub 2007 Apr 26.